GSTM1 and neoplasm: In another study, Ruoling Gao and colleagues developed curcumin-hemoglobin nanoparticles (Cur@Hb) Drug release in a simulated in vitro tumor microenvironment showed that more than 60% of curcumin was released from Cur@Hb at 72 h.